| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.07B | 54.27B | 56.09B | 52.37B | 50.00B | 53.35B |
| Gross Profit | 20.72B | 15.03B | 22.03B | 21.29B | 20.11B | 22.96B |
| EBITDA | 14.89B | 14.40B | 14.16B | 14.23B | 12.09B | 14.99B |
| Net Income | 4.85B | 5.56B | 5.50B | 5.29B | 4.34B | 6.35B |
Balance Sheet | ||||||
| Total Assets | 64.27B | 70.06B | 65.33B | 68.59B | 61.12B | 64.49B |
| Cash, Cash Equivalents and Short-Term Investments | 3.17B | 5.54B | 4.68B | 5.29B | 3.68B | 6.88B |
| Total Debt | 3.70B | 3.75B | 2.43B | 3.46B | 4.02B | 6.17B |
| Total Liabilities | 15.71B | 17.54B | 16.53B | 23.72B | 19.81B | 25.86B |
| Stockholders Equity | 48.57B | 52.52B | 48.80B | 44.87B | 41.30B | 38.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.93B | 3.13B | 4.09B | 951.00M | 6.84B |
| Operating Cash Flow | 0.00 | 5.58B | 5.12B | 6.23B | 3.32B | 8.56B |
| Investing Cash Flow | 0.00 | -4.08B | -2.91B | -2.54B | -2.62B | -1.69B |
| Financing Cash Flow | 0.00 | -573.00M | -2.84B | -2.38B | -3.91B | -3.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥49.09B | 8.58 | ― | 4.01% | -3.24% | 1.11% | |
72 Outperform | ¥1.02T | 8.70 | 19.60% | 1.94% | 3.42% | 30.95% | |
69 Neutral | ¥228.17B | 8.58 | ― | 2.67% | 8.13% | 7.00% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥158.96B | 9.30 | 14.78% | 2.95% | 16.84% | 22.03% | |
61 Neutral | ¥923.60B | 9.73 | 11.06% | 2.88% | 8.32% | 24.62% | |
58 Neutral | ¥152.98B | 14.03 | 8.95% | 3.39% | 20.87% | 16.79% |